Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. - Wikidata - awgldk - TriplyDB

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

http://www.wikidata.org/entity/Q34204026

about

START or SMART? Timing of Antiretroviral Therapy Initiation and Cardiovascular Risk for People With Human Immunodeficiency Virus Infection Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence When to start antiretroviral therapy: as soon as possible HIV and aging: emerging research issues Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patients Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010 Inflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort study The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults Association of low level viremia with inflammation and mortality in HIV-infected adults Cardiovascular Complications of HIV in Endemic Countries.Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.HIV Infection and Acute Stroke: A Case Report and a Review of the Literature.HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.Systemic effects of inflammation on health during chronic HIV infection Coagulation and morbidity in treated HIV infection.Frailty and Pre-Frailty in a Contemporary Cohort of HIV-Infected Adults Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals.Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems.Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy.Residual immune dysregulation syndrome in treated HIV infection.Association between systemic inflammation and obstructive sleep apnea in men with or at risk for HIV infection Inflammatory cytokines drive CD4+ T-cell cycling and impaired responsiveness to interleukin 7: implications for immune failure in HIV disease.Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection.Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.Biomarkers and HIV-associated cardiovascular disease.Chronic HIV disease and activation of the coagulation system HIV-1 infection is associated with changes in nuclear receptor transcriptome, pro-inflammatory and lipid profile of monocytes.Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders Elevated rates of intracerebral hemorrhage in individuals from a US clinical care HIV cohort.HIV, dementia and antiretroviral drugs: 30 years of an epidemic.Immunologic basis of cardiovascular disease in HIV-infected adults.Immune dysregulation and vascular risk in HIV-infected patients: implications for clinical care.Cardiovascular implications from untreated human immunodeficiency virus infection.Inflammatory Markers Associated with Coronary Heart Disease in Persons with HIV Infection.The immunologic effects of mesalamine in treated HIV-infected individuals with incomplete CD4+ T cell recovery: a randomized crossover trial

P2860

Q26753830-6F6B890E-15A7-44F2-B64B-F0201041358B Q26825762-72408587-5733-4E11-8AE2-0C7A5E383CBD Q27006767-2F663D24-D5E0-4B43-BF93-5E5297871F72 Q27016011-8B515B70-DBE8-4D41-BFEF-48C44FB2FD06 Q27024262-E391693C-8C95-4969-8B59-640043237A3B Q27324621-6DCDFEC6-803B-4AA9-AA1C-10807F1DB478 Q27690715-34FF547E-F494-4BDE-A3DB-EA505B9A4608 Q28484274-D6797AD3-FCE6-476B-A586-6E19931C92C3 Q28535156-DBD08965-BFB4-4628-AB20-E073C521FC9A Q28740565-3F6CACB4-EA70-4308-B6E7-BD99B00A15F4 Q28743237-4FF3392E-EBE6-4886-A19C-A7199436D339 Q30244655-92DC6BEC-5F9D-4CF6-BBC1-D4AF4B211497 Q30245379-1C2176CB-5A88-4E2A-B99B-A3AF82D12E26 Q30248286-D2A556BD-C209-429C-A1EE-3189B4D1E03F Q30670446-34014064-EC47-4909-8C0C-14099F1D15D1 Q30839904-1E668DC1-5DFF-4693-8DF7-EDB8FF0C8E1F Q31118978-E5406822-F0FA-47B7-9BB2-A625117C1AE2 Q33577551-166C4933-3E43-4CBD-AE63-9DE43A79D5D0 Q33614424-30A28984-E1E6-4000-879A-B05036D2A4B1 Q33813894-597095D8-6EBF-4AC8-8E74-FD05BE96C2A1 Q33880782-EB84D6E7-C70E-4656-A13C-D9D978058B2B Q33917180-FC8A09E9-743A-45A1-AFA2-05AECD9172C8 Q33926735-FF7126BC-C393-4D0C-9442-5FEA5738E2BC Q34016057-A3218F63-DD42-4786-AFA1-9052A3C1ABAB Q34020121-9F4108A4-B9AE-4786-A497-3242A13512F6 Q34036498-1AAA4D02-8282-4534-B955-C3E56894B460 Q34229695-99779DC4-BF57-46CD-A75F-125EA82F20BC Q34315572-00E0902F-B4A5-49D0-9593-132F128D7EEF Q34315579-90055330-9EAE-4905-AE12-E4EA8DC67723 Q34335486-6C58F875-C2BD-46B0-B749-0DA38AEEA9E1 Q34342368-FC313A9F-8D6C-4F19-9D04-CC8B43C41EA4 Q34459345-41D4667B-9974-4D0D-8ED1-71B8AC3D10C1 Q34517239-2B8FF90C-9958-4DED-9E7A-54F0E5D9F344 Q34553819-338EC530-C27F-4C59-B00B-EBFFABB5F111 Q34573511-0AA35A51-8796-48C5-B207-73C85604EB28 Q34638205-6930B765-B8D0-411A-9145-86D3BD94E530 Q34764372-94D47989-FF4B-4338-A4B9-BF3611C81654 Q34793193-C4C80A95-7FA6-4F0F-80C1-D0C855810086 Q34796153-2C603829-E1E7-4870-9787-CD7FC36BF370 Q34818798-2E498C17-4873-4B20-8FF8-D9AE625D5CAA

P2860

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

http://www.wikidata.org/entity/Q34204026

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@ast

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@en

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@nl

type

label

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@ast

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@en

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@nl

prefLabel

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@ast

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@en

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@nl

P1433

Q34204026-858B6678-647A-493C-BA30-CB06F17B3616

P1476

Q34204026-01466F22-18A7-4CF9-A48B-4FC1D536C2CF

P2093

Q34204026-00451A9D-4887-4166-945A-16EE6A24C694

Q34204026-62D87499-83F1-4D0D-9B08-97EB8A78FDAC

Q34204026-8C78623E-CA90-4E16-B14A-FEE2EEE55DBA

Q34204026-9B0D0BF3-5BD6-457F-852C-4915FF0218D9

Q34204026-A2D6A6FF-D715-4ACB-AAB6-0721EE2FE4C3

Q34204026-C283915A-BB4D-477F-BF97-12C68362A07C

Q34204026-CC93E565-C6AF-4A5D-9294-6D193ED0FA1C

Q34204026-F62C1857-83D1-49D4-9E8F-CD5F7EA66590

P2860

Q34204026-04FD2187-EBBE-4D99-AB86-42B81B03A1EF

Q34204026-11319732-D503-44C1-B312-C0EB5947F72C

Q34204026-185CEB4E-5A50-4373-9075-D21969638D70

Q34204026-256F868E-30FC-4327-9AA1-5E86F8D290D1

Q34204026-2ED3DA18-43C7-42C9-A47A-0F60DE364BCA

Q34204026-2ED8345D-D4B2-4280-9576-C8E5733B447A

Q34204026-37D06919-61AC-4A90-8080-D612FE8E0F4E

Q34204026-3A47570C-E5C6-47FE-8AD8-84D1A3DF9275

Q34204026-460040DA-CBCB-49EC-B02C-B2DD5F83BC6C

Q34204026-464055B6-F03E-451B-BEAB-06A507FF2D50

P304

Q34204026-41402D40-0392-423C-9249-2922F59DFA1D

P31

Q34204026-D6C81EBA-445A-4E09-87FF-1A25BA3884CC

P356

Q34204026-E0DC0095-A940-466A-B374-F252A9EF6ECD

P407

Q34204026-7477E7A5-1324-4FCD-B44D-68413D0D6795

P433

Q34204026-6476D2D9-2D5E-4962-A556-2D9749BBA829

P478

Q34204026-5DC1F784-91D0-436C-9E9D-2BAAB46DD1A5

P50

Q34204026-79F99611-1EFF-4A08-A926-54ACBC46F375

P577

Q34204026-3EA4C24B-312E-455B-A7C9-A7B323649673

P698

Q34204026-49579F29-76CA-4B17-A0A2-C0B95817375E

P921

Q34204026-89A96954-1E25-4DB7-9C57-0370A823F325

Q34204026-AFD635F1-9351-4E7A-B843-9116AC157231

P932

Q34204026-3360DC6B-7758-45CE-877E-5E899D35CBF9

P356

QAI.0B013E3181E66216

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.

@en

P2093

Andrew R Zolopa

http://www.w3.org/2001/XMLSchema#string

Andy I Choi

http://www.w3.org/2001/XMLSchema#string

Carl Grunfeld

http://www.w3.org/2001/XMLSchema#string

Constance Benson

http://www.w3.org/2001/XMLSchema#string

Peter Bacchetti

http://www.w3.org/2001/XMLSchema#string

Phyllis C Tien

http://www.w3.org/2001/XMLSchema#string

Rebecca Scherzer

http://www.w3.org/2001/XMLSchema#string

Russell Tracy

http://www.w3.org/2001/XMLSchema#string

P2860

Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study

Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era.

Multiple imputation: a primer.

Effect of early versus deferred antiretroviral therapy for HIV on survival.

Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

Changes in the risk of death after HIV seroconversion compared with mortality in the general population.

Association of antiretroviral therapy with fibrinogen levels in HIV-infection.

P304

316-322

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E3181E66216

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Michael G Shlipak

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20581689

http://www.w3.org/2001/XMLSchema#string

P921

P932

2955817

http://www.w3.org/2001/XMLSchema#string